Omics-Insights: Your Weekly Genomics & Proteomics Digest

Welcome to our latest Omics newsletter, your portal for the freshest updates and innovations in genomics. This week's newsletter brings you the latest updates from the dynamic world of Omics. In this edition, we bring you the latest developments in the dynamic world of Omics, including key industry news, strategic collaborations, skill development essentials for finding a new job, & essential career tips for omics professionals.

This week's latest news in the field of Omics:

Scale Biosciences Launches "100 Million Cell Challenge" with Ultima Genomics and Nvidia

Scale Biosciences has announced the launch of its "100 Million Cell Challenge" grant program in collaboration with Ultima Genomics and Nvidia. This initiative invites researchers worldwide to submit proposals for large-scale single-cell sequencing projects that analyze at least 1 million cells, with no upper limit, across various biological systems. The program will offer significantly subsidized costs for library preparation and sequencing services, and selected projects will gain early access to Scale Bio’s latest QuantumScale technology, which can handle up to 2 million cells per run. Participants will also benefit from high-throughput sequencing and accelerated computing services provided through the partnerships with Ultima and Nvidia. Project proposals are being accepted until October 15, with evaluations occurring on a rolling basis. Giovanna Prout, President and CEO of Scale Bio, emphasized the program’s potential to drive new discoveries in precision medicine and complex biological systems.

Alpenglow Biosciences Secures $24M for 3D Spatial Pathology Platform Development

Alpenglow Biosciences, a leader in 3D spatial biology, has secured a total of $24 million through contracts from the Advanced Research Projects Agency for Health (ARPA-H) and the National Institutes of Health (NIH), as well as additional investments. The funding will support the development of Alpenglow’s AI-driven 3D Spatial Biology platform aimed at precision tumor removal. This five-year ARPA-H contract, worth up to $21 million, is part of the Biden administration's Cancer Moonshot initiative. Collaborating with the University of Washington’s Liu Biophotonics Lab, Harvard’s Mahmood AI Lab, and Vanderbilt University Medical Center, Alpenglow aims to create a platform that offers near real-time, high-resolution 3D imaging to accurately identify tumor margins, potentially reducing repeat surgeries and improving patient outcomes. The contract also includes FDA regulatory support and reimbursement strategies through the Project Accelerator Transition Innovation Office (PATIO) program.

Stanford Study Reveals Two Key Molecular Shifts During Aging

New research from Stanford University highlights two significant periods of molecular change during aging, occurring around the ages of 44 and 60. The study, published in Nature Aging, involved a comprehensive analysis of clinical lab data from 108 individuals aged 25 to 75, examining transcriptomic, proteomic, and metabolomic patterns, along with blood cytokines and lipid profiles. The researchers also profiled microbial communities in various body sites. They found notable molecular shifts around age 44, affecting functions such as skin, muscle, and cardiovascular health, and another set of changes around age 60, influencing skin, muscle, kidney function, and immune response. These findings offer new insights into the nonlinear dynamics of aging and may lead to better diagnostic and preventive strategies for age-related diseases. However, further research is needed to validate and expand upon these results.

DNAnexus and Galatea Bio Partner to Enhance Genomic Analysis in Underserved Populations

DNAnexus and Galatea Bio have announced a strategic collaboration to improve the analysis and accessibility of genomic datasets from non-European populations. Under this partnership, Galatea Bio will utilize DNAnexus' Precision Health Data Cloud to manage and analyze these datasets, while DNAnexus will incorporate Galatea’s local ancestry and ancestry-adjusted polygenic risk score algorithms into its platform, benefiting its network of over 48,000 users across 48 countries. This collaboration aims to address the significant gap in precision health for non-European populations. DNAnexus CEO Thomas Laur highlighted the partnership as a step towards advancing global health equity.

Sophia Genetics DDM Platform Receives CE Marking Under EU IVDR

Sophia Genetics has obtained CE marking for its Data-Driven Medicine (DDM) platform under the European Union's In Vitro Diagnostic Regulation (IVDR). This cloud-based, deep learning software-as-a-service platform integrates genomic data with clinical data such as diagnostic tests, imaging, and pathology to support drug discovery, patient care, and disease diagnosis. Daan Van Well, Chief Legal and Compliance Officer at Sophia Genetics, stated that this certification reinforces the platform's cutting-edge status and compliance, offering customers confidence in their analysis needs. Earlier this year, Sophia Genetics partnered with Microsoft and Nvidia to use the DDM platform in commercializing a scalable whole-genome sequencing solution for clinical research and healthcare.

Current Live Roles at Kinetica:

Account Manager – Proteomics - Belgium

Account Manager – Proteomics - Switzerland

Account Manager – Proteomics - Boston

Business Development Manager - Proteomics Reagents - DACH

Business Development Manager - Proteomics Reagents - USA

Account Manager – Mid-Atlantic – Genomics reagents

Sales Specialist - NGS - Boston

Director of Product Management - LS Capital Equipment - Europe

Director of Applications Support - Genomics - West Coast

Operation Manager - LS Reagents - UK

Field Service Engineer - Imaging Equipment - Germany

Job Hunting Tips from an Omics Specialist Recruiter: Dos and Don’ts for Your Resume

Navigating the job market in the omics field—whether genomics, proteomics, metabolomics, or another specialization—requires a strategic approach. As an omics specialist recruiter, I've seen what makes candidates stand out and what common pitfalls can hinder their job search. Here are some key tips and dos and don'ts to help you land your next role in this competitive field.

Dos:

• Include a Strong Summary: Start with a brief summary that highlights your key qualifications, experience, and what you bring to the table.
• Use Keywords: Incorporate relevant keywords from the job description to pass through applicant tracking systems (ATS).
• Quantify Achievements: Use numbers to quantify your accomplishments (e.g., "Managed a lab with a budget of $500K").
• Keep it Concise: Aim for a resume length of one to two pages, focusing on the most relevant and recent experiences.
• Proofread: Ensure your resume is free of typos and grammatical errors. Consider having a peer review it.

Don’ts:

• Avoid Overloading with Jargon: While technical terms are necessary, avoid excessive jargon that might confuse non-specialist HR personnel.
• Don’t Include Irrelevant Information: Omit experiences that don't relate to the job you're applying for, such as unrelated part-time jobs or obsolete skills.
• Don’t Use Passive Language: Use action verbs like "led," "developed," "analyzed," to describe your contributions.
• Avoid Including Personal Information: Skip unnecessary details like age, marital status, or a photo unless specifically requested.
• Don’t Lie or Exaggerate: Be honest about your skills and experiences. Misrepresenting yourself can backfire during interviews or reference checks.

By following these tips and refining your resume accordingly, you'll position yourself as a strong candidate in the competitive omics job market.

Skill Development Essentials for Finding a New Job

Navigating the job market in the Life Science field requires not just a strong scientific background but also a robust set of professional skills. Here are key skill development essentials to focus on when seeking a new job, along with useful tools and websites to help you:

Job Search Strategies

Indeed: Search for job openings, set up job alerts, and apply directly.

LinkedIn Jobs: Utilize the job search function and get job recommendations based on your profile.

Science Careers: Explore job listings specifically for scientists and researchers.

?Wrapping Up Another Omics-Insights:

Thank you for embarking on a journey into the dynamic world of Omics with Kinetica! Explore the latest genomics job opportunities, stay informed with industry news, and indulge in insightful blogs at www.kinetica.co.uk. Your curiosity drives my commitment to relevant content, and I'm here to provide insights that fuel your scientific endeavors. Feel free to reach out with any questions or feedback. Wishing you ongoing inspiration and discovery in your scientific pursuits. Until next week, may your experiments yield groundbreaking results, and may your Omics journey remain as fascinating as the science itself!